Domaines de compétences
Scientific expertise: Cell culture; Biomedical Imaging, Recombinant DNA and Protein Technology
Teaching expertise: Biochemistry, Toxicology
Build up and manage the Research Office at EPFL regarding its concept, processes, method of evaluation/statistics and resource management in collaboration with the team specific coordinators having the ReO's concept in mind: success as a team and open for sharing.
Travail en cours
As Head of the Research Office
- Contribute with high quality implementation work of the duties and initiatives for improving ReO's service concept,
- Provide high quality reports to the Director of Research Affairs.
As Executive Manager of the fellowship programme "EPFL Fellows" (MSC COFUND)
- Manage the "EPFL Fellows" COFUND projects regarding their implementation, processes, method of evaluation/statistics and resource management in collaboration with the Vice-Provost for Research and the Programme Manager,
- Reporting to the EC as described in the Grant Agreement.
- Secure funding of the programme through submission of new proposals to the EC.
Caroline Vandevyver received her degree in biochemistry in 1985 from the Katholieke Universiteit Leuven, Belgium and her Ph.D. degree in biotechnology at the same university in 1989.
She joined the Biomedical Research Institute "Dr. L- Willems Instituut" in Hasselt, Belgium, in 1989. Subsequently, she has worked there on T cell mediated autoimmune diseases (Multiple Sclerosis, Rheumatoid Arthritis), genetic association and linkage studies in multifactorial diseases, mutation analysis of genetic disorders (Phenylketonuria, alpha 1 anti-trypsine deficiency, congenital adrenal hyperplasia) and the development of active and passive immune therapies for cancer.
She joined EPFL in 2000 at the Laboratory of Chemical Biotechnology headed by Prof. Ruth Freitag, where she was responsible for the cell culture lab and the (recombinant) protein purification and characterization. She joined the Laboratory of Lanthanide Supramolecular Chemistry (LCSL) in May 2006, where she was responsible for the live cell imaging project with Lanthanide complexes.
In 2005, she joined the Office of the Research Commission. Her duties there were the management of national and international fellowship programs, the management of local research awards and the promotion of research performed at EPFL. In August 2013, she was nominated coordinator of the International Funding, one of the pillars of the Research Office at EPFL. Since January 2017, she is the Head of EPFL's Research Office.
|Head of Unit||Research Office (ReO)||Vice‐presidency for Research, École Polytechnique Fédérale de Lausanne (EPFL)||January 2017 â present|
|Research Office (ReO), Coordinator International Funding||Vice‐presidency of Academic Affairs||École Polytechnique Fédérale de Lausanne (EPFL)||August 2013 â December 2016|
|Research Commission Office SNSF EPFL||Vice‐presidency of Academic Affairs||École Polytechnique Fédérale de Lausanne (EPFL)||September 2009 â August 2013|
|Senior Scientist||Faculty of Basic Sciences, “Institute of Chemical Sciences and Engineering” (ISIC, Laboratory of Lanthanide Supramolecular Chemistry (LCSL)||École Polytechnique Fédérale de Lausanne (EPFL)||September 2005 â September 2009|
|Scientist||Faculty of Basic Sciences, “Institute of Chemical Sciences and Engineering” (ISIC), Laboratory of Chemical Biotechnology (LBCH)||École Polytechnique Fédérale de Lausanne (EPFL)||September 2000 â August 2005|
|Department Head of Biotechnology Unit and Member of the Board||Biomedical Research Institute “Dr. L. Willems‐Instituut”||University of Hasselt (B)||January 1990 â June 1997|
|Department Head of Clinical Chemistry||Biomedical Research Institute “Dr. L. Willems‐Instituut”||University of Hasselt (B)||June 1989 â December 1989|
Sélection de publications
|Lodewyckx L, Vandevyver C, Vandervorst C, Van Steenbergen W, Raus J, Michiels L.
Hum Mutat, 18(3), 2001
|Mutation detection in the alpha-1 antitrypsin gene (PI) using denaturing gradient gel electrophoresis.|
|VanderBorght A, Geusens P, Vandevyver C, Raus J, Stinissen P.
Reumatology (Oxford), 39(11), 2000
|Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient.|
|Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L,
J Bone Miner Res, 14(9), 1999
|Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.|
|Motmans K, Thirion S, Janssens J, Raus J, Vandevyver C.
Eur J Cancer Prev, 7 S72, 1998
|Redirecting human T-cell specificity by functional expression of a chimeric T-cell receptor.|
|VanderBorght A, van der Aa A, Geusens P, Vandevyver C, Raus J, Stinissen P.
J Immunol Methods, 223(1), 1999
|Identification of overrepresented T cell receptor genes in blood and tissue biopsies by PCR-ELISA.|